Drug Discovery and Development

Home>>Drug Discovery and Development

Metformin Clinical DDI Study Design That Enables an Efficacy- and Safety-Based Dose Adjustment Decision

Introduction Metformin is an orally administered drug prescribed for the treatment of Type 2 diabetes. It is known to decrease hepatic glucose production, by inhibiting gluconeogenesis, and [...]

Transporters In Drug Development Based On Recent ITC Recommendations

Introduction Transporters are membrane proteins highly expressed in various organs of humans. They play a pivotal role in the absorption and disposition of both endogenous and exogenous [...]

Webinar: State of the Art in Clinical Transporter DDI Evaluation

Webinar Download Originally Hosted: Thursday, June 13, 2019 11:30am - 12:30pm EDT State of the Art in Clinical Transporter DDI Evaluation This presentation summarized the state-of-the-art in [...]

2019-10-09T12:33:18-04:00May 28, 2019|Categories: Drug Transporters, Webinars|Tags: , , |

Characterization of angiographic features and validation of a chronic wet AMD rabbit model induced by DL-AAA

Characterization of angiographic features and validation of a chronic wet AMD rabbit model induced by DL-AAA Vatsala Naageshwaran, John Quach, Nicholas Cook, Kayla Martinez, Ashley Renteria, Jenny Walters, [...]